title: Antileukemic immunity associated with antineutrophil antibody production after allogeneic hematopoietic SCT for myeloid/NK-cell precursor acute leukemia.
authors.forename: Hi
authors.initials: H
authors.lastname: Suzuki
authors.forename: T
authors.initials: T
authors.lastname: Suzuki
authors.forename: A
authors.initials: A
authors.lastname: Kamijo
authors.forename: S
authors.initials: S
authors.lastname: Oota
authors.forename: H
authors.initials: H
authors.lastname: Sato
authors.forename: A
authors.initials: A
authors.lastname: Hangaishi
authors.forename: T
authors.initials: T
authors.lastname: Takahashi
authors.forename: Y
authors.initials: Y
authors.lastname: Kanda
authors.forename: T
authors.initials: T
authors.lastname: Motokura
authors.forename: S
authors.initials: S
authors.lastname: Chiba
authors.forename: M
authors.initials: M
authors.lastname: Kurokawa
mesh_terms: D000328:Adult; D001323:Autoantibodies / Q000276:immunology; D003907:Dexamethasone / Q000627:therapeutic use; D020544:Graft vs Leukemia Effect / Q000276:immunology*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D007951:Leukemia, Myeloid / Q000276:immunology* / Q000628:therapy; D017254:Leukemic Infiltration / Q000276:immunology; D008297:Male; D009503:Neutropenia / Q000188:drug therapy / Q000209:etiology / Q000276:immunology; D009504:Neutrophils / Q000276:immunology*; D011239:Prednisolone / Q000627:therapeutic use; D012008:Recurrence
chemical_list: D001323:Autoantibodies; D003907:Dexamethasone; D011239:Prednisolone